MedPath

A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)

Not Applicable
Completed
Conditions
Friedreich's Ataxia
Interventions
Procedure: Cardiac magnetic resonance imaging (CMR)
Procedure: Exercise-stress test
Procedure: Echocardiography (ECHO)
Procedure: Cardiac-related blood studies
Registration Number
NCT02840669
Lead Sponsor
Adverum Biotechnologies, Inc.
Brief Summary

Friedreich's ataxia (FA) is an autosomal recessive disease with an incidence of 1/50,000 in the Caucasian population. The main manifestations of FA are progressive sensory and cerebellar ataxia and cardiomyopathy (CM). It is the most common form of inherited ataxia. A severe CM affects \~60% of FA patients, mostly young adults, and leads to cardiac failure then death. Currently, no therapy can change the course of this severe cardiomyopathy.

This study is designed to characterize the cardiac manifestations of FA using cardiac magnetic resonance (CMR), echocardiography, serum cardiac biomarkers and evaluation of fatigue severity, in the context of the neurological disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Healthy Volunteers (Controls)Cardiac magnetic resonance imaging (CMR)-
Friedreich's AtaxiaCardiac magnetic resonance imaging (CMR)-
Friedreich's AtaxiaExercise-stress test-
Friedreich's AtaxiaEchocardiography (ECHO)-
Friedreich's AtaxiaCardiac-related blood studies-
Healthy Volunteers (Controls)Echocardiography (ECHO)-
Healthy Volunteers (Controls)Cardiac-related blood studies-
Healthy Volunteers (Controls)Exercise-stress test-
Primary Outcome Measures
NameTimeMethod
Echocardiogram2 hours
Level of cardiac biomarkers in serum30 minutes
Fatigue Severity Scale30 minutes
Exercise-stress test2 hours
Cardiac magnetic resonance imaging (CMR)2 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hôpital Pitié-Salpêtrière, AP-HP

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath